首页> 外文会议>American College of Veterinary Internal Medicine Forum >CANINE ADULT STEM CELLS; THEIR BIOLOGY AND THERAPEUTIC POTENTIAL IN HEARTDISEASE
【24h】

CANINE ADULT STEM CELLS; THEIR BIOLOGY AND THERAPEUTIC POTENTIAL IN HEARTDISEASE

机译:犬成人干细胞;他们在心脏病中的生物学和治疗潜力

获取原文

摘要

In pet pedigree dogs cardiac disease is the third biggest cause of mortality after cancer and 'old age' and is therefore of significant importance in Veterinary practice. Acquired cardiac diseases in dogs are predominantly seen in two major categories; cardiomyopathies and valvular degeneration, with congenital causes of disease generally being very rare.l'2. Risk of death from cardiac disease increases with the age of the patient, and is also highly breed specific. For example, large breed dogs, such as Great Danes and Irish Wolfhounds are at major risk of developing dilated cardiomyopathy (DCM) whereas the Cavalier King Charles Spaniel has a significant risk of developing myxomatous mitral valve disease (MVMD).1 Managing cardiac disease morbidityin the dog has been the focus of significant pharmaceutical research, with the key goal being the improvement of quality of life first and foremost, followed by increased longevity. The need for the study of cardiac diseases in the dog is evident, and the use of stem cells for this is an exciting prospect, not only for study of disease processes in vitro, but also for their future therapeutic potential in vivo.
机译:在宠物血统犬心脏病中,心脏病是癌症和“老年”后的第三大死亡原因,因此在兽医实践中具有重要意义。在两大类中,狗的心脏病患者主要见到;心肌病和瓣膜变性,先天性疾病原因通常是非常罕见的。心脏病死亡风险随着患者的年龄而增加,并且也具有高度品种的特异性。例如,大型犬类,如大丹麦和爱尔兰猎犬,旨在发育扩张的心肌病(DCM)的主要风险,而Cavalier King Charles Spaniel具有显着发育乳糜素二尖瓣病的风险(MVMD).1管理心脏病的MITIBITYIN狗一直是重要的制药研究的重点,主要目标是提高生命质量第一,其次是持续的寿命。对狗心脏病的研究的需要是明显的,并且使用干细胞的使用是一种令人兴奋的前景,不仅用于研究体外疾病过程,而且还用于其未来体内治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号